HAYWARD, Calif. (AP) _ Anthera Pharmaceuticals Inc. (ANTH) on Monday reported a loss of $13 million in its fourth quarter.
The Hayward, California-based company said it had a loss of 36 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.
For the year, the company reported that its loss widened to $55.5 million, or $1.61 per share. Revenue was reported as $145,000.
In the final minutes of trading on Monday, the company's shares hit 71 cents. A year ago, they were trading at $2.92.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANTH at https://www.zacks.com/ap/ANTH
Keywords: Anthera Pharmaceuticals, Earnings Report